BETA Technologies, Inc. (NYSE: BETA) ("BETA" or "the Company"), an electric aerospace company, today announced it will ...

Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The ...

The consensus estimate for Q1 2026 revenue is $26.97 million, and the earnings are expected to come in at -$0.50 per share. The full year 2026's revenue is expected to be $132.59 million, and the ...

Net sales of $23.2 million, up 54% compared to $15.0 million in the second quarter of 2024. Durable Medical Equipment (DME) channel net sales of $18.6 million, up 31% compared to $14.3 million in the ...

Beta Bionics, Inc., a leader in diabetes management solutions, announced it will release its first quarter financial results for 2025 on May 6, 2025, after market close. Management will hold a ...

Smart beta strategy blends passive and active investing, focusing on volatility, quality, and value factors. Learn how it ...

Beta Bionics, Inc. has announced that it will release its financial results for the second quarter of 2025 after the markets close on July 29, 2025. Following the release, company management will host ...